Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-01-03 @ 6:47 PM
Study NCT ID:
NCT03236792
Status:
COMPLETED
Last Update Posted:
2022-09-29
First Post:
2017-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-20
First Submit QC Date:
None
Study First Post Date:
2017-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-28
Last Update Post Date:
2022-09-29
Last Update Post Date Type:
ACTUAL